These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27455999)

  • 41. Root Cause Analysis of Adverse Events in an Outpatient Anticoagulation Management Consortium.
    Graves CM; Haymart B; Kline-Rogers E; Barnes GD; Perry LK; Pluhatsch D; Gearhart N; Gikas H; Ryan N; Kurtz B
    Jt Comm J Qual Patient Saf; 2017 Jun; 43(6):299-307. PubMed ID: 28528624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of the chromogenic factor X assay in patients transitioning from argatroban to warfarin therapy.
    Austin JH; Stearns CR; Winkler AM; Paciullo CA
    Pharmacotherapy; 2012 Jun; 32(6):493-501. PubMed ID: 22511112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR.
    Sandén P; Renlund H; Svensson PJ; Själander A
    Thromb Haemost; 2017 Jan; 117(1):27-32. PubMed ID: 27652593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
    Perona S; Ford M; Rindone J
    J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Derivation and Validation of a Search Algorithm to Retrospectively Identify CRRT Initiation in the ECMO Patients.
    Guru PK; Singh TD; Passe M; Kashani KB; Schears GJ; Kashyap R
    Appl Clin Inform; 2016; 7(2):596-603. PubMed ID: 27437064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sensitivity and specificity of an algorithm based on medico-administrative data to identify hospitalized patients with major bleeding presenting to an emergency department.
    Oger E; Botrel MA; Juchault C; Bouget J
    BMC Med Res Methodol; 2019 Oct; 19(1):194. PubMed ID: 31627721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study.
    Sjögren V; Byström B; Renlund H; Svensson PJ; Oldgren J; Norrving B; Själander A
    PLoS One; 2017; 12(7):e0181000. PubMed ID: 28700711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding.
    Stewart WS; Pettit H
    Am J Emerg Med; 2013 Aug; 31(8):1251-4. PubMed ID: 23763937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin.
    Dager WE; King JH; Regalia RC; Williamson D; Gosselin RC; White RH; Tharratt RS; Albertson TE
    Pharmacotherapy; 2006 Aug; 26(8):1091-8. PubMed ID: 16863486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of bleeding in older patients taking warfarin.
    Spyropoulos AC
    Ann Intern Med; 2001 Oct; 135(7):548; author reply 549. PubMed ID: 11578159
    [No Abstract]   [Full Text] [Related]  

  • 51. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
    Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
    Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients.
    Jones KL; Barnett C; Gauthier M; Boster B; Espirito JL; Michaud LB
    J Oncol Pharm Pract; 2012 Mar; 18(1):122-7. PubMed ID: 21364079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A rule-based electronic phenotyping algorithm for detecting clinically relevant cardiovascular disease cases.
    Esteban S; Rodríguez Tablado M; Ricci RI; Terrasa S; Kopitowski K
    BMC Res Notes; 2017 Jul; 10(1):281. PubMed ID: 28705240
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study.
    Chang HY; Zhou M; Tang W; Alexander GC; Singh S
    BMJ; 2015 Apr; 350():h1585. PubMed ID: 25911526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastrointestinal bleeding risk of non-vitamin K oral anticoagulants is similar to warfarin - a Japanese retrospective cohort study
.
    Shirai T; Yamamoto T; Kawasugi K; Kuyama Y; Kita H
    Int J Clin Pharmacol Ther; 2016 Nov; 54(11):841-846. PubMed ID: 27569738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Association Between Bleeding and the Incidence of Warfarin Discontinuation in Patients with Atrial Fibrillation.
    Simon TA; Pan X; Kawabata H; Huang HY; Azoulay L
    Cardiovasc Ther; 2016 Apr; 34(2):94-9. PubMed ID: 26763662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial.
    Dignan R; Keech AC; Gebski VJ; Mann KP; Hughes CF;
    Int J Cardiol; 2013 Oct; 168(6):5378-84. PubMed ID: 24083884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of bleeding in older patients taking warfarin.
    Kajubi S
    Ann Intern Med; 2001 Oct; 135(7):548-9. PubMed ID: 11578160
    [No Abstract]   [Full Text] [Related]  

  • 59. Unexpected effects of unintended consequences: EMR prescription discrepancies and hemorrhage in patients on warfarin.
    Turchin A; Shubina M; Goldberg S
    AMIA Annu Symp Proc; 2011; 2011():1412-7. PubMed ID: 22195204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The analysis of bleeding risk-prediction scores should include all major bleeds.
    Gage BF; Radford MJ
    J Am Coll Cardiol; 2013 Jan; 61(4):481-482. PubMed ID: 23347784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.